Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornélie Fanton D'Andon

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Therapeutic Drug Monitoring|May 17, 2022
Failure of Risk Assessment After Paracetamol Overdose-A Short CommunicationOulfa Boussetta-Charfi, Cornélie Fanton D'Andon, HoanVu Nguyen, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 18, 2022
Ceftazidime dosing in obese patients: is it time for more?Cornélie Fanton D'Andon, Patricia Correia, Josselin Rigaill, et al.
Therapeutic Drug Monitoring|August 1, 2022
Relationship Between Plasmatic Metformin Concentration and Renal Replacement Therapy: A Multicenter Cohort StudyLise Demaretz, Guillaume Claisse, Cornélie Fanton-D'Andon, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Therapeutic Drug Monitoring|May 17, 2022
Failure of Risk Assessment After Paracetamol Overdose-A Short CommunicationOulfa Boussetta-Charfi, Cornélie Fanton D'Andon, HoanVu Nguyen, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 18, 2022
Ceftazidime dosing in obese patients: is it time for more?Cornélie Fanton D'Andon, Patricia Correia, Josselin Rigaill, et al.
Therapeutic Drug Monitoring|August 1, 2022
Relationship Between Plasmatic Metformin Concentration and Renal Replacement Therapy: A Multicenter Cohort StudyLise Demaretz, Guillaume Claisse, Cornélie Fanton-D'Andon, et al.
Pageof 1